IV-fluid minibags, mainly manufactured in Puerto Rico, are widely used 50-250 mL solution bags that infuse antibiotics and other medications intravenously. The minibag shortage impacts hospitals nationwide, hindering normal patient care, and pharmacy and nursing practices.
ECRI Institute announces the release of a special Health Devices guidance article featuring recommendations and alternative solutions for coping with the minibag shortage. The guidance article also features functional equivalency data for IV solution bags. This data employs the brainpower of ECRI Institute’s CrossCHEQ service, which identifies acceptable alternatives for medical-surgical supplies and implants.
The publicly available guidance article identifies alternative products from B. Braun Medical Inc., Baxter International, Fresenius Kabi, and Hospira Inc. Links to resources from the Institute for Safe Medication Practices (ISMP) and the American Society of Health-System Pharmacists (ASHP) are included in the report.